🔔 Get instant alerts when MARKSANS files quarterly results on BSE Start free trial →

Marksans Pharma Limited — Financials & Forensics

Sector: Healthcare · NSE: MARKSANS · BSE: 524404 · ISIN: INE750C01026

₹197.76
Closing price
08 May 2026
-21.1%
1-year price change
₹8,095 Cr
Market cap
19.3×
P/E ratio (trailing)
25.4%
Return on Equity (FY)
0.45%
Dividend yield
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts BOT
🚨 MARKSANS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MARKSANS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime
MARKSANS price
Loading…
Compare with:
Loading chart…

Annual P&L snapshot

Line item FY22FY23FY24FY25FY26
Revenue from operations ₹1,491 Cr ₹1,852 Cr ₹2,177 Cr ₹262 Cr ₹2,951 Cr
EBITDA ₹259 Cr ₹339 Cr ₹459 Cr ₹53 Cr ₹601 Cr
EBITDA margin 17.4% 18.3% 21.1% 20.2% 20.4%
Profit after tax ₹187 Cr ₹265 Cr ₹315 Cr ₹38 Cr ₹420 Cr

Source: Marksans Pharma Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

Never miss a filing again

1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
Get started — it's free →
14-day Pro trial included · No credit card required

About Marksans Pharma Limited on Indian Stock Alerts

Indian Stock Alerts tracks Marksans Pharma Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Marksans Pharma Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.